# Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory

**Authors:** Sina Frischholz, Ev-Marie Schuster, Myriam Grotz, Christine Schülein, Julia Benz, Katharina Kocher, Lucia Klotz, Szilard Varga, Theresa Hiltner, Rayya Alsalameh, Jan Esse, Johannes Träger, Jürgen Held, Frederik Graw, Jürgen Pahle, Bernd Spriewald, Luca Gattinoni, Veit R. Buchholz, Felix Drost, Benjamin Schubert, Simon Rothenfußer, Dirk H. Busch, Christian Bogdan, Kilian Schober

PMC · DOI: 10.1038/s41590-026-02421-w · Nature Immunology · 2026-02-24

## TL;DR

This study shows that certain T cells become metabolically inactive after vaccination, which helps them survive long-term in the body.

## Contribution

The study reveals that naive-like memory T cells are metabolically quiescent and are preferentially maintained for long-term immunity.

## Key findings

- CD8+ central memory T cells are the most metabolically active during the acute phase after vaccination.
- Naive-like memory T cells are metabolically quiescent and are maintained 26 years postvaccination.
- Metabolic shutdown occurs in effector T cells during the acute immune response.

## Abstract

Metabolic activity shapes cell fate but remains challenging to capture in vivo with high resolution. Here we performed longitudinal metabolic and phenotypic profiling of human antigen-specific CD8+ T cells after yellow fever vaccination using flow cytometry and single-cell RNA sequencing. As assessed by protein translation rates, CD8+ T cells upregulated glycolysis to fuel anabolic needs for proliferation but predominantly used oxidative phosphorylation for energy production during the acute phase (days 7–28) after vaccination. Simultaneously, CD8+CD62L+CD45RA− central memory T cells were the most metabolically active subset, whereas CD8+CD62L−CD45RA+ effector T cells underwent metabolic shutdown. Weakly differentiated CD8+CD62L+CD45RA+CD95− naive-like memory T cells showed minimal activity, relied solely on oxidative phosphorylation and were preferentially maintained 26 years postvaccination, reinforcing the link between cellular quiescence and longevity. Our study highlights quiescence as a key feature for long-term immunological memory formation in humans.

Schober and colleagues show that effector CD8+ T cells undergo metabolic shutdown, CD8+ central memory T cells are the most metabolically active, and naive-like memory T cells are quiescent during the acute phase of the immune response and represent the dominant population of memory CD8+ T cells after yellow fever vaccination in humans.

## Linked entities

- **Proteins:** CD8A (CD8 subunit alpha), SELL (selectin L), FAS (Fas cell surface death receptor)
- **Diseases:** yellow fever (MONDO:0020502)

## Full-text entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, GEM (GTP binding protein overexpressed in skeletal muscle) [NCBI Gene 2669] {aka KIR}, Cd27 (CD27 antigen) [NCBI Gene 21940] {aka S152, Tnfrsf7, Tp55}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Tcf7 (transcription factor 7, T cell specific) [NCBI Gene 21414] {aka TCF-1, Tcf1}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, Cd19 (CD19 antigen) [NCBI Gene 12478], IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Klrg1 (killer cell lectin-like receptor subfamily G, member 1) [NCBI Gene 50928] {aka 2F1-Ag, MAFA, MAFA-L}, CLEC3B (C-type lectin domain family 3 member B) [NCBI Gene 7123] {aka MCDR4, TN, TNA}, Ccr7 (C-C motif chemokine receptor 7) [NCBI Gene 12775] {aka CC-CKR-7, CCR-7, CD197, Cdw197, Cmkbr7, EBI1}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, CD28 (CD28 molecule) [NCBI Gene 403646], Cd38 (CD38 antigen) [NCBI Gene 12494] {aka ADPRC 1, Cd38-rs1, I-19}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, Fas (Fas cell surface death receptor) [NCBI Gene 14102] {aka APO1, APT1, CD95, TNFR6, Tnfrsf6, lpr}, CXCR3 (C-X-C motif chemokine receptor 3) [NCBI Gene 2833] {aka CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, Ncam1 (neural cell adhesion molecule 1) [NCBI Gene 17967] {aka CD56, E-NCAM, NCAM-1, Ncam}, TNFRSF9 (TNF receptor superfamily member 9) [NCBI Gene 3604] {aka 4-1BB, CD137, CDw137, ILA, IMD109}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Ptcra (pre T cell antigen receptor alpha) [NCBI Gene 19208] {aka gp33, pT-alpha, pT-alpha-TCR, pT[a], pTa, pTalpha}, IL2 (interleukin 2) [NCBI Gene 403989]
- **Diseases:** viral infection (MESH:D014777), TN (MESH:C562719), cytotoxicity (MESH:D064420), infected (MESH:D007239), rabies (MESH:D011818), COVID-19 (MESH:D000086382), polio (MESH:D011051), hepatitis A (MESH:D056486), bacterial (MESH:D001424), pertussis (MESH:D014917), Yellow fever (MESH:D015004), tetanus (MESH:D013746), diphtheria (MESH:D004165), rick-borne encephalitis (MESH:D004675), typhoid (MESH:D014435), meningococcal disease (MESH:D008589), Japanese encephalitis (MESH:D004672), hepatitis B (MESH:D006509), cholera (MESH:D002771)
- **Chemicals:** AF647 (MESH:C569686), HEPES (MESH:D006531), harringtonine (MESH:C062500), Puromycin (MESH:D011691), penicillin (MESH:D010406), AF488 (-), Polybrene (MESH:D006583), ATP (MESH:D000255), L-glutamine (MESH:D005973), CO2 (MESH:D002245), DMSO (MESH:D004121), reactive oxygen species (MESH:D017382), oligomycin (MESH:D009840), hexosamine (MESH:D006595), PBS (MESH:D007854), Linoleic acid (MESH:D019787), 2-DG (MESH:D003847), pentose phosphate (MESH:D010428), streptomycin (MESH:D013307), Cy5.5 (MESH:C098793), nitrogen (MESH:D009584), Ammonium chloride (MESH:D000643), arachidonic acid (MESH:D016718), TMRM (MESH:C401833), L (MESH:D007930), D-biotin (MESH:D001710), HCl (MESH:D006851), gentamicin (MESH:D005839)
- **Species:** Listeria monocytogenes (species) [taxon 1639], Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Yellow fever virus (no rank) [taxon 11089], Mus musculus (house mouse, species) [taxon 10090], Variola virus (smallpox virus, no rank) [taxon 10255], LCMV [taxon 11623], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Mutations:** P14
- **Cell lines:** clCasp-3hi — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), TCM — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_7967), RD114 — Homo sapiens (Human), Embryonal rhabdomyosarcoma, Cancer cell line (CVCL_1751)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956582/full.md

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956582/full.md

---
Source: https://tomesphere.com/paper/PMC12956582